ARCHIVES

Intensity Modulated Therapy Safer Than Three-Dimensional Radiation

This article is from The Cancer Letter archive.

Vol. 34 No. 6 | June 24, 2011

Download PDF Visit The Full Archive

Related Articles

Two Phase III Afatinib Trials Demonstrate Prolonged Survival

May 30, 2014

Guest Editorial: The Walue of Quality of Life Data In Judging Patient Benefit: experts Respond To ODAC

September 3, 1999

BMS Settles Charges Of Obstructing Generics

March 14, 2003

ASRO President Tells Colleagues To Take Charge

October 26, 1990

New Report On Survival Data Available From NCI

July 25, 1975

NCA Asks HHS To Exempt From DRG Peer Reviewed Institutions With At Least 25 Protocol Patients

August 12, 1983